Search Results - "Jenkins, Dorea P."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Establishment and genomic characterization of a sporadic malignant peripheral nerve sheath tumor cell line by Longo, Jody Fromm, Brosius, Stephanie N., Znoyko, Iya, Alers, Victoria A., Jenkins, Dorea P., Wilson, Robert C., Carroll, Andrew J., Wolff, Daynna J., Roth, Kevin A., Carroll, Steven L.

    Published in Scientific reports (11-03-2021)
    “…Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive Schwann cell-derived neoplasms that occur sporadically or in patients with neurofibromatosis…”
    Get full text
    Journal Article
  2. 2

    The 5-hydroxytryptamine receptor 1F stimulates mitochondrial biogenesis and angiogenesis in endothelial cells by Dupre, Tess V., Jenkins, Dorea P., Muise-Helmericks, Robin C., Schnellmann, Rick G.

    Published in Biochemical pharmacology (01-11-2019)
    “…[Display omitted] A hallmark of acute kidney injury (AKI) is vascular rarefication and mitochondrial dysfunction. Promoting vascular recovery following AKI…”
    Get full text
    Journal Article
  3. 3

    Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models by Jenkins, Dorea P, Turner-Ivey, Brittany, Fromm Longo, Jody, Carroll, Steven L

    Published in Journal of visualized experiments (17-05-2024)
    “…Patients with the autosomal dominant tumor susceptibility syndrome neurofibromatosis type 1 (NF1) commonly develop plexiform neurofibromas (PNs) that…”
    Get more information
    Journal Article
  4. 4

    Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor by Turner-Ivey, Brittany, Longo, Jody Fromm, Jenkins, Dorea P, Guest, Stephen T, Carroll, Steven L

    Published in Journal of visualized experiments (25-08-2023)
    “…Malignant Peripheral Nerve Sheath Tumors (MPNSTs) are derived from Schwann cells or their precursors. In patients with the tumor susceptibility syndrome…”
    Get more information
    Journal Article
  5. 5

    PDE5 inhibition rescues mitochondrial dysfunction and angiogenic responses induced by Akt3 inhibition by promotion of PRC expression by Corum, Daniel G., Jenkins, Dorea P., Heslop, James A., Tallent, Lacey M., Beeson, Gyda C., Barth, Jeremy L., Schnellmann, Rick G., Muise-Helmericks, Robin C.

    Published in The Journal of biological chemistry (25-12-2020)
    “…Akt3 regulates mitochondrial content in endothelial cells through the inhibition of PGC-1α nuclear localization and is also required for angiogenesis. However,…”
    Get full text
    Journal Article
  6. 6

    PDE5 inhibition rescues mitochondrial dysfunction and angiogenic responses induced by Akt3 inhibition by promotion of PRC expression by Corum, Daniel G, Jenkins, Dorea P, Heslop, James A, Tallent, Lacey M, Beeson, Gyda C, Barth, Jeremy L, Schnellmann, Rick G, Muise-Helmericks, Robin C

    Published in The Journal of biological chemistry (25-12-2020)
    “…Akt3 regulates mitochondrial content in endothelial cells through the inhibition of PGC-1α nuclear localization and is also required for angiogenesis. However,…”
    Get full text
    Journal Article